Elon's Vision
  • Contacts
  • Privacy Policy
  • Terms & Conditions
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Elon's Vision
No Result
View All Result
Home Stock

ZeptoMetrix Unveils PROtrol: Ensuring Quality Control for the Lateral Flow Immunoassay Sector

by
May 16, 2023
in Stock
0
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

ZeptoMetrix® is thrilled to present PROtrol TM, an innovative range of products specifically designed for antigen-based diagnostic methods. These meticulously developed third-party materials serve as faithful clinical specimen surrogates and offer a means to assess and monitor the efficacy of antigen-based assays, particularly lateral flow immunoassays employed in the detection of infectious diseases.

PROtrol stands out as the sole whole organism reference material that provides comprehensive testing data. Each product lot is accompanied by crucial information, including protein concentration and TCID50 value, effectively reducing the need for extensive qualification testing. By enhancing reproducibility, PROtrol optimizes resource allocation and processing time, significantly reducing the necessity for repeated testing.

Dr. Karuna Sharma, Vice President & Chief Scientific Officer, commented, “The rapid growth of antigen-based assays has underscored certain quality challenges. Inactivated, whole organism controls designed specifically for antigen tests empower manufacturers with the necessary tools to evaluate assay performance, resulting in higher-quality tests in the market.”

The first member of this product line, PROtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Isolate: USA-WA1/2020* (PROSARS(COV2)-587), addresses the current COVID-19 pandemic. ZeptoMetrix is committed to expanding the PROtrol product line beyond this crisis, ensuring the provision of high-quality controls to assay manufacturers striving to widen access to affordable and user-friendly diagnostics.

Evangeline Gonzalez, President of Antylia Diagnostics division, remarked, “The launch and expansion of PROtrol strengthen our position as the preferred partner for diagnostic test developers. As we collaborate with our diagnostic partners, ZeptoMetrix takes pride in the role PROtrol plays in extending global access to diagnostic testing, benefiting patients worldwide.”

For detailed information on how to order the new PROtrol and explore additional ZeptoMetrix products, please visit: https://www.zeptometrix.com

About ZeptoMetrix® ZeptoMetrix® enjoys a prominent standing as a respected industry leader, dedicated to designing, developing, and delivering innovative and reliable solutions for the infectious disease diagnostics market. With expertise in molecular diagnostics, encompassing external quality controls, verification panels, proficiency panels, and customized/OEM products and services, ZeptoMetrix sets the industry benchmark for performance and dependability, making it the preferred choice for independent third-party quality control materials.

Contact Information

Andrew Zenger
Global Product Manager
andrew.zenger@antylia.com
(716) 715-7417

The post ZeptoMetrix Unveils PROtrol: Ensuring Quality Control for the Lateral Flow Immunoassay Sector first appeared on BusinessMole.

Previous Post

How to Teach Austrian Economics to the Neighbor Kids

Next Post

What is a Press Release? A Clear Definition and Purpose

Next Post

What is a Press Release? A Clear Definition and Purpose

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest

Jay Bhattacharya on Public Health

October 12, 2021

That Bangladesh Mask Study!

December 1, 2021

Antitrust Regulation Assumes Bureaucrats Know the “Correct” Amount of Competition

November 24, 2021
Pints of champagne could be the next ‘Brexit dividend’

Pints of champagne could be the next ‘Brexit dividend’

December 24, 2021
Friday Feature: MCP Academy

Friday Feature: MCP Academy

0

0

0

0
Friday Feature: MCP Academy

Friday Feature: MCP Academy

May 9, 2025

P.T. Bauer’s Reminders on Foreign Aid

May 9, 2025
Luna Introduces PATRIOT Act Repeal Bill

Luna Introduces PATRIOT Act Repeal Bill

May 9, 2025

The Spanish Blackout Is a Warning to the World

May 9, 2025

Recent News

Friday Feature: MCP Academy

Friday Feature: MCP Academy

May 9, 2025

P.T. Bauer’s Reminders on Foreign Aid

May 9, 2025
Luna Introduces PATRIOT Act Repeal Bill

Luna Introduces PATRIOT Act Repeal Bill

May 9, 2025

The Spanish Blackout Is a Warning to the World

May 9, 2025

Disclaimer: ElonsVision.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • Contacts
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 ElonsVision. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 ElonsVision. All Rights Reserved.